200 related articles for article (PubMed ID: 23597914)
21. Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms.
Bui MM; Bagui TK; Boulware DC; Letson DG; Nasir A; Kaiser HE; Pledger WJ; Coppola D
In Vivo; 2007; 21(5):729-37. PubMed ID: 18019405
[TBL] [Abstract][Full Text] [Related]
22. Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3.
Schaefer KL; Brachwitz K; Wai DH; Braun Y; Diallo R; Korsching E; Eisenacher M; Voss R; Van Valen F; Baer C; Selle B; Spahn L; Liao SK; Lee KA; Hogendoorn PC; Reifenberger G; Gabbert HE; Poremba C
Cancer Res; 2004 May; 64(10):3395-405. PubMed ID: 15150091
[TBL] [Abstract][Full Text] [Related]
23. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
[TBL] [Abstract][Full Text] [Related]
24. Aberrant MAD2 expression in soft-tissue sarcoma.
Hisaoka M; Matsuyama A; Hashimoto H
Pathol Int; 2008 Jun; 58(6):329-33. PubMed ID: 18477210
[TBL] [Abstract][Full Text] [Related]
25. Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma.
Fletcher CD
Am J Surg Pathol; 1992 Mar; 16(3):213-28. PubMed ID: 1317996
[TBL] [Abstract][Full Text] [Related]
26. Immunophenotypic characterization of high grade pleomorphic sarcomas: a demographic and immunohistochemical study in a major referral center of Pakistan.
Shah H; Pervez S
J Pak Med Assoc; 2005 Mar; 55(3):101-4. PubMed ID: 15852744
[TBL] [Abstract][Full Text] [Related]
27. [Imprint cytological features of soft tissue sarcomas].
Sonobe H
Rinsho Byori; 1999 Jul; 47(7):614-21. PubMed ID: 10442039
[TBL] [Abstract][Full Text] [Related]
28. Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases.
Hisaoka M; Ishida T; Kuo TT; Matsuyama A; Imamura T; Nishida K; Kuroda H; Inayama Y; Oshiro H; Kobayashi H; Nakajima T; Fukuda T; Ae K; Hashimoto H
Am J Surg Pathol; 2008 Mar; 32(3):452-60. PubMed ID: 18300804
[TBL] [Abstract][Full Text] [Related]
29. Expression of betacellulin, heparin-binding epidermal growth factor and epiregulin in human malignant fibrous histiocytoma.
Yamamoto T; Akisue T; Marui T; Nakatani T; Kawamoto T; Hitora T; Nagira K; Fujita I; Matsumoto K; Kurosaka M
Anticancer Res; 2004; 24(3b):2007-10. PubMed ID: 15274392
[TBL] [Abstract][Full Text] [Related]
30. Molecular hierarchy of heparin-binding EGF-like growth factor-regulated angiogenesis in triple-negative breast cancer.
Yotsumoto F; Tokunaga E; Oki E; Maehara Y; Yamada H; Nakajima K; Nam SO; Miyata K; Koyanagi M; Doi K; Shirasawa S; Kuroki M; Miyamoto S
Mol Cancer Res; 2013 May; 11(5):506-17. PubMed ID: 23443317
[TBL] [Abstract][Full Text] [Related]
31. Expression profiling in soft tissue sarcomas with emphasis on synovial sarcoma, gastrointestinal stromal tumor, and leiomyosarcoma.
West RB
Adv Anat Pathol; 2010 Sep; 17(5):366-73. PubMed ID: 20733355
[TBL] [Abstract][Full Text] [Related]
32. Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF.
Hollborn M; Tenckhoff S; Jahn K; Iandiev I; Biedermann B; Schnurrbusch UE; Limb GA; Reichenbach A; Wolf S; Wiedemann P; Kohen L; Bringmann A
Mol Vis; 2005 Jun; 11():397-413. PubMed ID: 15988409
[TBL] [Abstract][Full Text] [Related]
33. Proteolytic activation of heparin-binding EGF-like growth factor by membrane-type matrix metalloproteinase-1 in ovarian carcinoma cells.
Koshikawa N; Mizushima H; Minegishi T; Eguchi F; Yotsumoto F; Nabeshima K; Miyamoto S; Mekada E; Seiki M
Cancer Sci; 2011 Jan; 102(1):111-6. PubMed ID: 20946474
[TBL] [Abstract][Full Text] [Related]
34. Detection and cellular localization of heparin-binding epidermal growth factor-like growth factor mRNA and protein in human atherosclerotic tissue.
Reape TJ; Wilson VJ; Kanczler JM; Ward JP; Burnand KG; Thomas CR
J Mol Cell Cardiol; 1997 Jun; 29(6):1639-48. PubMed ID: 9220349
[TBL] [Abstract][Full Text] [Related]
35. Soft tissue sarcomas.
Spiguel A
Cancer Treat Res; 2014; 162():203-23. PubMed ID: 25070237
[TBL] [Abstract][Full Text] [Related]
36. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
[TBL] [Abstract][Full Text] [Related]
37. Unique cell membrane expression of topoisomerase-II alpha as a useful diagnostic marker of liposarcoma.
Endo H; Hirokawa M; Ishimaru N; Tanaka Y; Yamashita M; Sakaki M; Hayashi Y; Sano T
Pathol Int; 2004 Mar; 54(3):145-50. PubMed ID: 14989736
[TBL] [Abstract][Full Text] [Related]
38. Pleomorphic leiomyosarcoma of the soft parts: a reassessment by histology and immunohistochemistry of pleomorphic soft tissue sarcomas.
Yamamoto I; Oshiro Y; Fukuda T; Tsuneyoshi M
Oncol Rep; 1999; 6(3):533-7. PubMed ID: 10203587
[TBL] [Abstract][Full Text] [Related]
39. TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities.
Koelsche C; Renner M; Hartmann W; Brandt R; Lehner B; Waldburger N; Alldinger I; Schmitt T; Egerer G; Penzel R; Wardelmann E; Schirmacher P; von Deimling A; Mechtersheimer G
J Exp Clin Cancer Res; 2014 Apr; 33(1):33. PubMed ID: 24726063
[TBL] [Abstract][Full Text] [Related]
40. Malignant hemangiopericytoma and other sarcomas with hemangiopericytoma-like pattern.
Tsuneyoshi M; Daimaru Y; Enjoji M
Pathol Res Pract; 1984 May; 178(5):446-53. PubMed ID: 6087304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
